Clinical Trial: The Effectiveness of Extracorporeal Shock Wave Therapy for Elbow Osteochondritis Dissecans (OCD)

U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07884578) titled 'The Effectiveness of Extracorporeal Shock Wave Therapy for Elbow Osteochondritis Dissecans (OCD)' on Oct. 05.

Brief Summary: Extracorporeal shock wave therapy was performed on athletes aged 15-18 years with lateral maxillary chondritis of the elbow, and X-ray, blood tests, and MRI were conducted to evaluate the treatment progress.

Study Start Date: Feb. 12, 2020

Study Type: INTERVENTIONAL

Condition: Elbow Osteochondritis Dissecans

Intervention: DEVICE: Extracorporeal Shock Wave Therapy

Extracorporeal shock wave therapy (Storz) was used on osteochondritis dissociated at the humeral capitula, 3000 impulses at 28kV.

DEVICE: Ext...